The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country

American Journal of Gastroenterology

Volumn 95, Issue 1, 2000, Pages 50-56

  Rollan, Antonio ^a   Giancaspero, Rossana ^a   Fuster, Francisco ^b   Acevedo, Claudia ^a   Figueroa, Cecilia ^a   Hola, Karen ^b   Schulz, Marcela ^a   Duarte, Ignacio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL NAVAL ALMIRANTE NEF   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FAMOTIDINE; OMEPRAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; DEVELOPING COUNTRY; DISEASE COURSE; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; REINFECTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-ULCER AGENTS; CHILE; DEVELOPING COUNTRIES; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FAMOTIDINE; FEMALE; FOLLOW-UP STUDIES; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; RECURRENCE; TINIDAZOLE;

EID: 0033989183     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00759-5     Document Type: Article

References (52)

1. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther. 9:1995;45-51.
2. Marshall B.J. Helicobacter pylori. Am J Gastroenterol. 89:1994;S116-S128.
3. Hopkins R.J., Vial P.A., Ferreccio C., et al. Seroprevalence of Helicobacter pylori in Chile Vegetables may serve as one route of transmission . J Infect Dis. 168:1993;222-226.
4. Hansson L.-E., Nyrén O., Hsing A.W., et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 335:1996;242-249.
5. Parsonnet J. Helicobacter pylori in the stomach - A paradox unmasked. N Engl J Med. 335:1996;278-280.
6. Bazzoli F., Zagari R.M., Fossi S., et al. Short-term low dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol, Hepatol. 6:1994;773-777.
7. Damianos AJ, McGarrity TJ. Treatment strategies for Helicobacter pylori infection. Am Fam Physician 1997;55:2765-74,2784-6.
8. Chiba N., Matisko A., Sinclair P., et al. Helicobacter pylori from bench to bedside. Can J Gastroenterol. 11:1997;589-596.
9. Borody T.J., Andrews P., Mancuso N., et al. Helicobacter pylori reinfection rate, in patients with cured duodenal ulcer. Am J Gastroenterol. 89:1994;529-532.
10. Cutler A.F., Schubert T.T. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am J Gastroenterol. 88:1993;1359-1361.
11. Hentschel E., Brandstätter G., Dragosics B., et al. Effect of ranitidine, and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med. 328:1993;408-412.
12. Helicobacter pylori in Peptic Ulcer Disease. JAMA. 272:1994;65-69.
13. Muñoz N., Vivas J., Buiatti E., et al. Chemoprevention trial on precancerous lesions of the stomach in Venezuela Summary of study design and baseline data . IARC Sci Publ. 1996;125-133.
14. Simsek H., Kadayifci A., Tatar G. Low eradication rates of Helicobacter pylori with omeprazole plus amoxycillin Combination in a Turkish population. Am J Gastroenterol. 91:1996;1062. (letter).
15. Buiatti E., Muñoz N., Vivas J., et al. Difficulty in eradicating Helicobacter pylori in a population at high risk for stomach cancer in Venezuela. Cancer Causes Control. 5:1994;249-254.
16. Bell G.D., Powell K.U. Helicobacter pylori reinfection after apparent eradication - the Ipswich experience. Scand J Gastroenterol. 215:(suppl):1996;96-104.
17. Mitchell H.M., Hu P., Chi Y., et al. A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China). Gastroenterology. 114:1998;256-261.
18. Sack R.B., Gyr K. Helicobacter pylori in developing world. Lancet. 341:1993;1274-1275.
19. Guisset M., Coton T., Rey P., et al. Helicobacter pylori infection in developing countries. Med Trop. 57:1997;77-82.
20. Coelho L.G., Passos M.C., Chausson Y., et al. Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study. Scand J Gastroenterol. 27:1992;362-366.
21. Figueroa G., Acuña R., Troncoso M., et al. Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients. Am J Gastroenterol. 91:1996;1395-1399.
22. Goh K.L., Navaratnam P., Peh S.C. Reinfection and duodenal ulcer relapse in south-east Asian patients following successful Helicobacter pylori eradication Results of a 2- year follow-up . Eur J Gastroenterol Hepatol. 8:1996;1157-1160.
23. Figueroa G., Acuna R., Troncoso M., et al. Helicobacter pylori infection in Chile. Clin Infect Dis. 25:1997;983-989.
24. Russell R.G., Wasserman S.S., O'Donnoghue M., et al. Serological response to Helicobacter pylori among children, and teenagers in northern Chile. Am J Trop Med Hyg. 49:1993;189-191.
25. Correa P., Schmidt B.A. The relationship between gastric cancer and the ratio of gastric to duodenal ulcer. Aliment Pharmacol Ther. 9:1995;13-19.
26. Graffar M. Une méthode de classification sociale d'echantillons de population. Courier. 6:1956;445-449.
27. Ho S.A., Hoyle J.A., Lewis F.A., et al. Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol. 29:1991;2543-2549.
28. Rollan A., Giancaspero R., Arrese M., et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection after antibiotic treatment. Am J Gastroenterol. 92:1997;1268-1274.
29. Cutler A.F., Havstad S., Ma C.K., et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology. 109:1995;136-141.
30. Fabre R., Sobhani I., Laurent-Puig P., et al. Polymerase chain reaction assay for the detection of Helicobacter pylori in gastric biopsy specimens comparison with culture, rapid urease test, and histopathological tests . Gut. 35:1994;905-908.
31. Price A.B. The Sydney system Histological division . J Gastroenterol Hepatol. 6:1991;209-222.
32. Zaitoun A.M. Histological study of chronic gastritis from the United Arab Emirates using the Sydney system of classification. J Clin Pathol. 47:1994;810-815.
33. Hopkins R.J., Girardi L.S., Turney E.A. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence A review . Gastroenterology. 110:1996;1244-1252.
34. Forbes G.M. Helicobacter pylori. Current issues and new directions. J Gastroenterol Hepatol. 12:1997;419-424.
35. Blum A.L. Helicobacter pylori and peptic ulcer disease. Scand J Gastroenterol. 214:(suppl):1996;24-27.
36. Miehlke S., Lehn N., Meining A., et al. Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy. Eur J Gastroenterol Hepatol. 8:1996;1161-1163.
37. Louw J.A., Lucke W., Jaskiewicz K., et al. Helicobacter pylori eradication in the African setting, with special reference to reinfection and duodenal ulcer recurrence. Gut. 36:1995;544-547.
38. Rodrigo Saez L., Riestra Menendez S., Fernandez Rodriguez E., et al. Epidemiological study of the prevalence of Helicobacter pylori infection in the general population in Asturias, Spain. Rev Esp Enferm Dig. 89:1997;511-522.
39. Miehlke S., Bayerdörffer E., Lehn N., et al. Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 7:1995;975-978.
40. Megraud F. How should Helicobacter pylori infection be diagnosed? Gastroenterology. 113:1997;S93-S98.
41. Xia H.X., Gilvarry J., Beattie S., et al. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. Am J Gastroenterol. 90:1995;1221-1225.
42. Forbes G.M., Glaser M.E., Cullen D.J.E., et al. Duodenal ulcer treated with Helicobacter pylori eradication Seven-year follow-up . Lancet. 343:1994;258-260.
43. Bland J.M., Altman D.G. Survival probabilities (the Kaplan-Meier method). Br Med J. 317:1998;1572.
44. Moeschberger M.L., Klein J.P. Statistical methods for dependent competing risks. Lifetime Data Anal. 1:1995;195-204.
45. Abu-Mahfouz M.Z., Prasad V.M., Santogade P., et al. Helicobacter pylori recurrence after successful eradication. 5-year follow-up in the United States. Am J Gastroenterol. 92:1997;2025-2028.
46. van der Ende A., van der Hulst R.W., Dankert J., et al. Reinfection versus recrudescence in Helicobacter pylori infection. Aliment Pharmacol Ther. 11:(suppl 1):1997;55-61.
47. Gisbert J.P., Mur M., Boixeda D., et al. One-week treatment with omeprazole, clarithromycin, and amoxicillin. High efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer. Med Clin (Barc). 108:1997;524-529.
48. Kuipers E.J. Helicobacter pylori and the risk and management of associated diseases Gastritis, ulcer disease, atrophic gastritis and gastric cancer . Aliment Pharmacol Ther. 11:(suppl 1):1997;71-88.
49. van der Hulst R.W., van der Ende A., Dekker F.W., et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA A prospective 1-year follow-up study . Gastroenterology. 113:1997;25-30.
50. Gisbert J.P., Boixeda D., Vila T., et al. Verification of decreased basal, and stimulated serum pepsinogen-I levels is a useful non-invasive method for determining the success of eradication therapy for Helicobacter pylori. Scand J Gastroenterol. 31:1996;103-110.
51. Burstein M., Monge E., Leon-Barua R., et al. Low peptic ulcer and high gastric cancer prevalence in a developing country with a high prevalence of infection by Helicobacter pylori. J Clin Gastroenterol. 13:1991;154-156.
52. Blaser M.J., Chyou P.H., Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 55:1995;562-565.